Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Endocrinology 2, 74–75 (1 February 2006) | doi:10.1038/ncpendmet0095
How reliable is newborn screening for congenital adrenal hyperplasia?
Abstract
Votava F et al. (2005) Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Eur J Endocrinol 152: 869–874 Synopsis Background Newborn screening (NBS) is routinely performed in order to identify neonates with inherited metabolic and endocrine disorders, including CONGENITAL ADRENAL HYPERPLASIA (CAH).
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
